Amarin Targets Positive 2026 Cash Flow with $70M Operating Expense Savings

Amarin Corporation announced plans to achieve $70 million in operating expense savings by June 30, 2026, as part of its strategy to target positive cash flow for the year 2026. The pharmaceutical company is focusing on financial efficiency and sustainability.